Chief Financial Officer

The Opportunity

We’re looking for a CFO who can own the full capital strategy—from defining valuation and funding pathways to leading a high-stakes Series A. You will be the financial and strategic counterpart to the CEO: shaping the fundraising architecture, driving investor engagement end-to-end, and translating complex science and milestones into a compelling, defensible investment narrative. Your work will connect R&D, Product, Operations, external advisors, and strategic partners into a unified fundraising engine that secures the capital required to scale Subsense.

Key Responsibilities

1. Investment Strategy & Fundraising Leadership

• Shape the fundraising strategy: round size, structure, timing, sequencing, investor tiering.
• Define capital allocation logic tied to milestones and long-term funding pathways.
• Craft the core investor narrative (market framing, positioning, value-creation path).
• Build strategy for competitive tension, syndicate composition, and negotiation positioning.
• Prioritize investor segments and define approach per segment.
• Partner with CEO on strategy, messaging, and board alignment.

2. Fundraising Execution

• Build and manage the investor pipeline across VCs, strategics, family offices, and crossover funds.
• Lead all investor interactions: outreach, screening, meetings, diligence coordination, closing.
• Own investor materials: deck, data room, trackers, diligence responses.
• Maintain consistent investor communication across updates and milestones.
• Coordinate advisors, legal, technical reviewers, and bankers (if engaged).
• Represent Subsense at fundraising-relevant conferences and strategic events.

3. Valuation Strategy & Execution

• Own valuation strategy, valuation assumptions, and defensibility of the valuation narrative.
• Develop equity economics and investment scenarios aligned with financial models and milestones.
• Run cap table modeling, dilution scenarios, and option pool planning.
• Present and defend valuation during investor discussions and diligence, define valuation boundaries and negotiation logic.

4. Fundraising Readiness & Company Alignment

• Align R&D, Product, and Operations milestones with capital-to-milestones logic and investor expectations.
• Ensure defensible KPIs, clean financials, and a coherent technical milestone trajectory.
• Translate scientific progress into measurable investor KPIs and funding logic.
• Drive internal preparedness for diligence: strategy clarity, documentation, risks, feasibility.
• Ensure internal alignment on fundraising timeline, critical path, and interdependencies.

5. Strategic Partnerships & Deal Support

• Evaluate partnerships (pharma, CROs, enterprise) for impact on valuation and fundraising leverage.
• Structure partnership terms, pilots, LOIs, and commercial frameworks that enhance investor credibility.
• Integrate partner traction and external validation into the fundraising narrative.
• Coordinate legal, technical, and commercial inputs for partnership-related diligence.
• Use strategic partners to strengthen negotiation leverage and valuation defensibility.

What You'll Bring

• Proven experience in venture-backed startups, deep-tech, medtech, biotech, or related high-complexity fields.

• Proven experience in top-tier financial institutions (investment banking, hedge funds, private equity, or asset management) with a track record in high-stakes financial analysis, transactions, or capital markets work.

• Proven record leading or materially driving $50–150M institutional fundraising rounds.

• Established relationships with top-tier VCs, strategics, family offices, or crossover funds.

• Direct experience structuring equity economics, valuation narratives, and cap table strategies.

• Fluency in investor processes, technical diligence, financial defensibility, and milestone-driven capital planning.

• Strong command of modeling logic, investment scenarios, and deal negotiation principles (built on top of existing company models).

• Exceptional communicator who can craft high-conviction investor stories and influence diverse senior stakeholders.

• Comfortable operating in scientific, regulated, and cross-functional environments with R&D, Product, and external advisors.